Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Katherine E.D. Giacoletti"'
Publikováno v:
Case Studies in Bayesian Methods for Biopharmaceutical CMC ISBN: 9781003255093
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93dfb0df874c96b97712c7968bac04ff
https://doi.org/10.1201/9781003255093-8
https://doi.org/10.1201/9781003255093-8
Autor:
Barbara J. Kuter, Eric Shaw, Keith S. Reisinger, Katherine E.D. Giacoletti, Shelly Senders, Luwy Musey, Edgardo A. Malacaman, Florian Schödel, Jonathan Hartzel, Richard T. Wiedmann
Publikováno v:
Vaccine. 33:2132-2140
Prior to 2006, M-M-R(®)II (measles, mumps, and rubella virus vaccine live) was manufactured using human serum albumin (HSA) and each dose of the vaccine contained a relatively small amount (≤0.3mg) of HSA. Because of specific regulatory requiremen
Autor:
O-E Iversen, Kristjan Sigurdsson, Joakim Dillner, Mark T. Esser, Jorma Paavonen, Frank J. Taddeo, Janine T. Bryan, S-E Olsson, Scott Vuocolo, F. X. Bosch, Slawomir Majewski, Eliav Barr, Margaret James, Katherine E.D. Giacoletti, Susanne K. Kjaer, N. Munoz
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 23:1147-1155
Background Quadrivalent human papillomavirus (HPV types 6/11/16/18) L1 VLP vaccine is highly effective in preventing HPV 6/11/16/18-related cervical and external genital disease. Herein, we evaluated the impact of the quadrivalent HPV 6/11/16/18 L1 V
Autor:
J. Hoye, G. Von Krogh, Carlos Alberto Petta, Mark T. Esser, A. Andersson-Ellstrom, Kristina Elfgren, O-E Iversen, Luisa L. Villa, Gretchen M. Tamms, Eliav Barr, Katherine E.D. Giacoletti, Heather L. Sings, Rosires Pereira de Andrade, Alfred Saah, Jorma Paavonen, Matti Lehtinen, Radha Railkar, Christian Malm, G. Riis-Johannessen, Frank J. Taddeo, Lisa Lupinacci, Margareta Steinwall, Ronaldo L.R. Costa, S-E Olsson, Janine T. Bryan
Publikováno v:
British Journal of Cancer
Human papillomavirus (HPV) causes cervical, vulvar, and vaginal cancers, precancerous dysplasia, and genital warts. We report data for the longest efficacy evaluation to date of a prophylactic HPV vaccine. In total, 552 women (16-23 years) were enrol
Publikováno v:
Statistical methods in medical research. 24(2)
A question of interest in many vaccine clinical development programmes is whether vaccine-induced serum antibody level can be used as a correlate of vaccine efficacy; that is, whether serum antibody levels induced by a candidate vaccine can reliably
Autor:
Katherine E.D. Giacoletti, Daron G. Ferris, Alfred J. Saah, Elmar A. Joura, Marc Steben, David Radley, Margaret James, Heather L. Sings, Cosette M. Wheeler, Matti Lehtinen, Jorma Paavonen, Richard M. Haupt, Darron R. Brown, Suzanne M. Garland
Publikováno v:
International journal of cancer. 129(11)
The impact of a human papillomavirus (HPV) vaccine on development of cervical intraepithelial neoplasia grade 2-3 or adenocarcinoma in situ (CIN2-3/AIS) in women with ongoing HPV16 or 18 infections prevaccination is reported. Seventeen thousand six-h
Autor:
Marc Steben, Laura A. Koutsky, Ole Erik Iversen, Lisa Lupinacci, Kristjan Sigurdsson, Patricia J. Garcia, Joakim Dillner, Amha Tadesse, Robert J. Kurman, Eng Tay, Luisa L. Villa, Daron G. Ferris, Nubia Muñoz, Elmar A. Joura, Richard M. Haupt, Evan R. Myers, F. Xavier Bosch, Jorma Paavonen, Warner K. Huh, Frank J. Taddeo, Sepp Leodolter, Sven Eric Olsson, Heather L. Sings, Janine T. Bryan, Slawomir Majewski, Darron R. Brown, Gonzalo Perez, Grace W.K. Tang, Margaret James, Teresa M. Hesley, Mauricio Hernández-Ávila, Eliav Barr, Katherine E.D. Giacoletti, Susanne K. Kjaer, Suzanne M. Garland, Christine C. Roberts, Kevin A. Ault, Cosette M. Wheeler
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Universidad del Rosario
instacron:Universidad del Rosario
As we contemplate the astonishing successes of human papillomavirus (HPV) vaccines, it is worthwhile to consider whether randomized controlled trials of the sort recently published in the Journal can ever show reductions in cervical cancer rates (1).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc677a1f29bb3f2e8026483e432b7d19
https://repository.urosario.edu.co/handle/10336/22479
https://repository.urosario.edu.co/handle/10336/22479
Autor:
Marc Steben, Richard M. Haupt, Elmar A. Joura, Ole Erik Iversen, Darron R. Brown, Matti Lehtinen, Sepp Leodolter, Nubia Muñoz, Suzanne M. Garland, Xavier Bosch, Janine T. Bryan, Sven Eric Olsson, Scott Vuocolo, Patricia J. Garcia, Slawomir Majewski, Teresa M. Hesley, Shuang Lu, Mauricio Hernández-Ávila, Eliav Barr, Luisa L. Villa, Katherine E.D. Giacoletti, Daron G. Ferris, Evan R. Myers, Lisa Lupinacci, Susanne K. Kjaer, Gonzalo Perez, Frank J. Taddeo, Cosette M. Wheeler, Kevin A. Ault, Christine C. Roberts, Kristjan Sigurdsson, Joakim Dillner, Jorma Paavonen, Eng Tay, Grace W.K. Tang, Laura A. Koutsky, Amha Tadesse, Robert J. Kurman
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Universidad del Rosario
instacron:Universidad del Rosario
The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by humoral immunity. We evaluated the correlation between quadrivalent HPV vaccine-induced serum anti-HPV responses and efficacy. 17,622 women were vaccinat
Autor:
Eliav Barr, Frances B. Alvarez, Katherine E.D. Giacoletti, Keith S. Reisinger, Derek Puchalski, Joanne Erick, Suzanne Lukac, Eduardo Lazcano-Ponce, Heather L. Sings, Mark T. Esser, Stan L. Block, Rudiwilai Samakoses
Publikováno v:
The Pediatric infectious disease journal. 26(3)
Administration of a quadrivalent HPV-6/ 1/16/18 vaccine to 16- to 26-year-old women was highly effective in preventing HPV-6/ 1/16/18-related cervical/vulvar/vaginal precancerous lesions and genital warts. As the risk of acquiring HPV significantly r
Autor:
Alfred Saah, Jorma Paavonen, Kristina Elfgren, Matti Lehtinen, Carlos Alberto Petta, John Høye, Gretchen M. Tamms, Sven-Eric Olsson, Luisa L. Villa, Scott Vuocolo, Rosires Pereira de Andrade, Mark T. Esser, Lisa Lupinacci, Agneta Andersson-Ellstrom, Ole-Erik Iversen, Geo von Krogh, Eliav Barr, Katherine E.D. Giacoletti, Ronaldo L.R. Costa, Christian Malm, Grete Riis-Johannessen, Margareta Steinwall
Publikováno v:
Vaccine. 25(26)
The duration of protection afforded by vaccines represents a critical test of their utility as public health interventions. Some vaccines induce long-term immunity, while others require booster doses. Vaccines that induce long-term protection are usu